TabMenu

Poverty and InequalitySexual and Reproductive HealthFamily, Maternal & Child HealthMethodology
Home

HPC Publications

Export 7 results:
Sort by: Author Title Type [ Year (Desc)]
Filters: Author is Alexander, G. C.  [Clear All Filters]
2018
Moore TJ, Zhang H, Anderson G, Alexander GC. Estimated Costs of Pivotal Trials for Novel Therapeutic Agents Approved by the US Food and Drug Administration, 2015-2016. JAMA Intern Med. 2018;178:1451-1457. Abstract
2017
Alexander GC, Ballreich J, Socal MP, Karmarkar T, Trujillo A, Greene J, Sharfstein J, Anderson G. Reducing branded prescription drug prices: A review of policy options. Pharmacotherapy. 2017. Abstract
Ballreich J, Alexander GC, Socal M, Karmarkar T, Anderson G. Branded prescription drug spending: a framework to evaluate policy options. J Pharm Policy Pract. 2017;10:31. Abstract
2016
Lyapustina T, Rutkow L, Chang HY, Daubresse M, Ramji AF, Faul M, Stuart EA, Alexander GC. Effect of a "pill mill" law on opioid prescribing and utilization: The case of Texas. Drug Alcohol Depend. 2016;159:190-7. Abstract
Chang HY, Lyapustina T, Rutkow L, Daubresse M, Richey M, Faul M, Stuart EA, Alexander GC. Impact of prescription drug monitoring programs and pill mill laws on high-risk opioid prescribers: A comparative interrupted time series analysis. Drug Alcohol Depend. 2016;165:1-8. Abstract
2015
Rutkow L, Chang HY, Daubresse M, Webster DW, Stuart EA, Alexander GC. Effect of Florida's Prescription Drug Monitoring Program and Pill Mill Laws on Opioid Prescribing and Use. JAMA Intern Med. 2015;175:1642-9. Abstract
Buttorff C, Andersen MS, Riggs KR, Alexander GC. Comparing employer-sponsored and federal exchange plans: wide variations in cost sharing for prescription drugs. Health Aff (Millwood). 2015;34:467-76. Abstract